Environmental contamination in households of patients with recurrent clostridium difficile infection by Shaughnessy, Megan Kosel
 Environmental Contamination in Households of Patients with 
Recurrent Clostridium difficile Infection 
 
 
 
A THESIS  
SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY 
OF MINNESOTA 
BY 
 
Megan Kosel Shaughnessy 
 
 
 
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS  
FOR THE DEGREE OF  
MASTER OF SCIENCE 
 
James Robert Johnson 
 
September 2014 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Megan Kosel Shaughnessy 2014 
 i 
ACKNOWLEDGEMENTS 
 
I would like to thank the co-investigators on the project, Drs. James R. Johnson (the Principal 
Investigator and my research mentor), Aleh Bobr (who assisted with household surveillance 
sampling), Michael Sadowsky (who provided the laboratory facilities), and Alexander Khoruts 
(who provided the study participants). Dr. Michael Kuskowski also assisted with the statistical 
analysis. My contributions to the work included study design (including creation of study 
protocols and materials), contacting and enrolling study participants, completing household study 
visits (including administering surveys and performing surveillance sampling), all laboratory 
work including bacteria isolation and molecular characterization, data collection and analysis 
from all study materials, statistical analysis, and all aspects of the thesis writing and preparation. 
My M.S. Thesis Committee was chaired by Dr. Johnson; while Drs. Paul Bohjanen, and David 
Boulware served as committee members. Stacy Holzbauer, at the Minnesota Department of 
Health and the Centers for Disease Control and Prevention, assisted with development of 
household surveillance methods and training of study team members. Chanlan Chun at the 
University of Minnesota assisted with laboratory analysis of household environmental samples. 
Brian Johnston at the Minneapolis Veterans Affairs Medical Center assisted with tcdC gene 
sequencing preparation and analysis.  
Funding support during my training was provided through a National Institutes of Health T32 
training grant to the University of Minnesota Infectious Disease Fellowship Program. Additional 
support was provided by the Office of Research and Development, Medical Research Service, 
Department of Veterans Affairs at the Minneapolis Veterans Affairs Medical Center. Lastly, I 
would like to thank my thesis advisor and research mentor for this project, Dr. James R. Johnson. 
 ii 
 
Abstract 
Background: Recurrent Clostridium difficile infection (R-CDI) is common and difficult 
to treat, potentially necessitating fecal microbiota transplantation (FMT). Although C. 
difficile spores can persist in the hospital environment and cause infection, little is known 
about their potential presence in the household environment. 
Methods: Households of R-CDI subjects in the peri-FMT period, and of geographically 
and age-matched controls, were analyzed for presence of C. difficile. Household 
environmental surfaces and fecal samples from humans and pets in the household were 
examined. Post-FMT subject households were also examined (environmental surfaces 
only). Participants were surveyed regarding their personal history and household cleaning 
habits. Environmental and fecal samples were cultured for C. difficile. Species identity 
and molecular characteristics of presumptive C. difficile isolates were determined using 
the PRO kit (Remel, USA), Gram staining, PCR, toxinotyping, tcdC gene sequencing, 
and pulsed-field gel electrophoresis (PFGE). 
Results: Environmental cultures detected C. difficile on ≥ 1 surface in 8/8 (100%) peri-
FMT households vs. 3/8 (38%) post-FMT households and 3/8 (38%) control households 
(P = 0.025). The most common C. difficile-positive surfaces were the vacuum (11/27, 
41%), toilet (8/30, 27%), and bathroom sink (5/29, 17%). C. difficile was detected in 3/36 
(8%) fecal samples (2 R-CDI subjects, 1 household member). Nine (90%) of 10 
households with multiple C. difficile-positive samples had a single genotype present each.  
 iii 
Conclusions: C. difficile was found in the household environment of R-CDI patients. 
Whether this is a cause or consequence of R-CDI is unknown. If household 
contamination leads to R-CDI, effective decontamination may be protective.  
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Introduction 
Infection rates and mortality due to Clostridium difficile infection (CDI) are increasing 
[1-2]. Recurrences of CDI also are common, with 20-30% of patients having a first 
recurrence, and 45% of these individuals subsequently having a second recurrence [3]. 
Some patients experience numerous recurrences, which ultimately may necessitate fecal 
microbial transplantation (FMT). Whether recurrent CDI (R-CDI) is from persistent C. 
difficile gut colonization between episodes, vs. new acquisition of C. difficile from the 
environment, is unknown.  
The hospital environment has been extensively studied as an external source for 
C. difficile acquisition. C. difficile spores can contaminate the hospital environment of 
inpatients with CDI, and can persist there for at least 5 months [4], require specific 
sporicidal cleaning practices (bleach, hydrogen peroxide vapor, UV technology, etc.) for 
adequate killing [5, 6], and contribute to subsequent transmission and disease [5]. In 
contrast, little is known regarding the possible presence of C. difficile spores in the 
household environment of CDI patients, including the physical environment and human 
and animal inhabitants. 
Humans and pets can also be asymptomatic C. difficile carriers. Reported carriage 
prevalence rates vary by host group, e.g., 1-3% for healthy adults, 20-30% for recently 
hospitalized patients, and 51% for long-term care facility residents during a CDI 
outbreak, consistent with increased carriage as a result of exposure to environmental 
contamination [7-8]. Up to 70% of healthy newborns and infants are also colonized with 
C. difficile [9]. C. difficile colonization has been shown in 10% of healthy household 
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dogs [10] and up to 40% of cats and dogs at veterinary clinics [11], although whether this 
relates to CDI in humans is unknown. 
The goal of the present study was to define the prevalence, persistence, 
epidemiologic correlates, and molecular characteristics of C. difficile in the household 
environment of R-CDI subjects, including environmental surfaces, humans, and pets. 
 
Methods 
Household enrollment. Subjects ≥ 18 years old with R-CDI who were referred to a 
University of Minnesota gastroenterology clinic, and were scheduled to undergo FMT in 
the immediate future, were offered study participation (peri-FMT group). Consideration 
for FMT required (1) a minimum of 2 spontaneous relapses following the initial CDI 
episode, each within a month of stopping antimicrobial therapy, and (2) documented 
failure of an advanced antimicrobial therapy regimen (vancomycin pulse/taper, or 
vancomycin plus rifaximin chaser). Control subjects of similar age and geographic 
location to case subject were offered participation as a convenience sample from among 
the investigators’ acquaintances. Co-habiting family members of all ages (defined as 
sleeping overnight in the same home as the index subject > 50% of the time) were also 
offered participation. Additionally, subjects from the same gastroenterology clinic who 
had undergone FMT for R-CDI 6 to 24 months prior to enrollment were offered 
participation, for household environmental sampling only (post-FMT group). Exclusion 
criteria for all index subjects included residence in a long-term care or rehabilitation 
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facility, or relocation to a new home within the previous 30 days. For control subjects, an 
additional exclusion criterion was a history of CDI or chronic diarrhea. There were no 
exclusion criteria for household members. 
 
Household visit. Each participating household was visited once by study personnel. Peri-
FMT households were visited between 7 days before and 10 days after the FMT 
procedure. At the beginning of the visit, the index subject and any participating 
household member(s) gave informed consent for participation. All participating subjects 
in peri-FMT and control households were given kits to collect a fecal sample, including 
from any household pets (mammals only).  
All participants completed a survey, administered by study personnel, that 
addressed history of CDI or other diarrheal illnesses, underlying medical conditions, 
current or recent (within 1 year) antibiotic use or healthcare facility exposure, personal 
hand hygiene, and CDI knowledge. Additionally, the household member responsible for 
the greatest share of housecleaning completed a survey regarding the usual cleaning 
frequency of specific household areas (described below), the estimated date when each 
area was last cleaned, and whether bleach products were commonly used in each area. A 
household cleaning frequency value was then calculated for each household, as the mean 
usual cleaning frequency for each targeted household area. (For additional details 
regarding the surveys and cleaning frequency scale, see the Table 1 footnotes.) 
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Environmental samples were obtained from pre-specified locations. A standard 
sampling method and list of surfaces was followed according to the “Clostridium difficile 
Household Study Environmental Sample Collection Protocol” from the Centers for 
Disease Control and Prevention (CDC) (personal communication, Stacy Holzbauer). 
Environmental samples were obtained with sterile, premoistened sponges (sponge-stick 
with neutralizing buffer, 3M, USA) using aseptic technique. Surfaces targeted in each 
household (if applicable) included the inside of the vacuum cleaner bag or intake 
compartment, diaper changing area, bathroom areas (toilet seat/handle, sinks/faucet, door 
handles/light switch), kitchen areas (refrigerator handle/shelf, microwave door, kitchen 
counter used for food preparation/ light switch, sink/faucet), door handles of main exit, 
telephone, computer keyboard, television remote control, and pet food/water dishes. As a 
negative control, a sponge was exposed briefly to air and replaced sterilely into the bag. 
Duplicate samples were permitted; e.g., if a household contained two bathrooms used 
regularly by the index subject, surfaces in both bathrooms were sampled. Sites sampled 
in most or all households (i.e., all except the diaper changing area and pet food/water 
dishes, which were sampled in 1 and 8 households, respectively) were defined as “core 
environmental sites”.  
  
Laboratory evaluation. C. difficile isolation from environmental samples was done using 
a modified CDC protocol. Sterile phosphate buffered saline with 0.1% Tween 80 (50 mL) 
was added to the sterile bags containing the environmental sample sponges. Bags were 
placed into a Stomacher 400 circulator (Seward Laboratory Systems, Davie, FL) at 260 
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RPM for 1 minute. The liquid was removed, placed into sterile centrifuge tubes, and 
centrifuged at 3500 x g for 15 minutes. Thereafter, 45 mL of buffer was removed and the 
pellet was resuspended in the remaining buffer. A 0.2 mL aliquot of the resulting 
suspension was plated in duplicate onto pre-reduced cycloserine-cefoxitin-fructose agar 
with horse blood and taurocholate (CCFA-HT, Anaerobic systems, USA). Additionally, 1 
mL of suspension was inoculated into cycloserine-cefoxitin-fructose broth (CCFB), to 
help increase the culture yield from the environmental samples [12].  
Fecal samples were processed using a single alcohol shock method involving a 
1:1 mixture of stool and 95% ethanol. The stool-ethanol mixture was held at room 
temperature for 45-60 minutes, with brief vortexing every 15 minutes. Samples were 
centrifuged at 3000 rpm for 10 minutes. After removal of the supernatant, the stool pellet 
was streaked onto pre-reduced CCFA-HT plates. 
All CCFA-HT plates and CCFB broth tubes were incubated at 37oC under 
anaerobic conditions for 48-72 hours. Suspected C. difficile colonies from CCFA-HT 
plates were further identified using McLung Toabe agar (criterion: lecithinase and lipase-
negative), blood agar (criterion: no hemolysis), PRO kit (Remel, USA), and Gram stain 
(criterion: spore forming, Gram-positive bacilli). Presumptive C. difficile colonies were 
further characterized by PCR detection of the pathogenicity locus (PaLoc), binary toxin 
(cdtB), and C. difficile toxin regulator tcdC genes; toxinotyping; and sequence analysis of 
tcdC for specific deletions [13-17]. Molecularly confirmed C. difficile isolates also 
underwent pulsed-field gel electrophoresis (PFGE) analysis, allowing assignment to an 
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established or novel North American pulsotype (NAP) based on 80% similarity in 
comparison with CDC reference profiles [18]. 
 
Statistical analysis. The three household groups (peri-FMT, post-FMT, and control) were 
compared according to demographic characteristics and results of environmental and 
fecal C. difficile sampling using Fisher’s exact test or student’s t-test, with a two-sided P 
< 0.05 considered significant. Number of C. difficile-positive core environmental sites per 
household group was evaluated using Poisson regression to adjust for potential 
confounding factors, including average case patient age, average number and age of 
household members, number of pets, household cleaning frequency, and bleach cleaning 
product use. The likelihood of a particular site yielding C. difficile was determined using 
site-specific logistic regression analysis, with adjustment for usual cleaning frequency 
and bleach cleaning product use.  
 
The study was approved by the Institutional Review Board at the University of 
Minnesota. 
 
Results 
Household surveillance. Overall, 8 peri-FMT and 8 control households underwent 
surveillance of the household environment and the human and animal residents. 
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Additionally, 8 post-FMT households, divided equally between 6 months and 2 years 
post-FMT, underwent environmental surveillance only. Household characteristics are 
shown in Table 1. The peri-FMT household characteristics are slightly skewed by 
household #1, which had 5 household members and 3 pets, while most households had 
between 0-3 household members and 0-2 pets (data not shown). Only 1 control household 
contained pets, compared with 4 households each in the peri- and post-FMT households. 
The three groups were otherwise similar according to measured demographic 
characteristics except for household cleaning frequency (which differed between peri-
FMT and post-FMT households) and the index subjects’ underlying medical conditions 
(which differed between peri-FMT and control households).   
 
Environmental samples. All 8 (100%) peri-FMT households, as compared with only 3/8 
(38%) control households, had at least one C. difficile-positive environmental sample (P 
= 0.025) (Table 2). Likewise, with 31 (10%) of 326 total core environmental samples 
positive for C. difficile, the mean number of C. difficile-positive core environmental 
samples was significantly greater for peri-FMT households (2.6) than control households 
(0.25) (P = 0.024) (Table 3). Among post-FMT households, the likelihood of C. difficile 
environmental contamination decreased with increasing elapsed time since FMT, with 
2/4 (50%) 6-months-post-FMT households but only 1/4 (25%) 2-years-post-FMT 
households having any C. difficile-positive surface (P > 0.1). Post-FMT households had a 
mean of only 1 C. difficile-positive core environmental sample per household, which did 
not differ significantly from control households (Table 3). The number of C. difficile-
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positive core environmental sites per household (as estimated using Poisson regression) 
for a given household group did not shift appreciably when adjusted for mean age of the 
index patient, mean number and age of household members, number of pets, household 
cleaning frequency, and bleach cleaning product use (Table 3).  
Although the 31 C. difficile-positive core environmental samples (i.e., all but one 
C. difficile-positive diaper changing area sample from a control household) were from 
diverse household sites, certain high-prevalence sites were over-represented (Table 4). 
The site most likely to be C. difficile-positive was the vacuum (11/27 [41%]), followed 
by the toilet (8/30 [27%]), and bathroom sink/faucet (5/29 [17%]). According to separate 
site-specific logistic regression models for each of the 3 most commonly contaminated 
sites (vacuum, toilet, bathroom sink/faucet), the odds of detecting C. difficile were not 
affected by usual cleaning frequency or bleach cleaning product use on the site.  
 
Fecal samples. Overall, of 36 fecal samples submitted, 3 (8%) yielded C. difficile (Table 
2). All 16 index subjects from peri-FMT and control households provided a fecal sample; 
of these, two index subjects from peri-FMT households (vs. none from control 
households) were C. difficile-positive. Both subjects had undergone FMT within 1 week 
prior to sample collection, and ultimately failed the FMT procedure due to R-CDI (vs. 
none of 6 C. difficile-negative peri-FMT index subjects; P = .036). As for other 
household members, participation rates were high, with only 1 peri-FMT household and 2 
control households lacking fecal samples from household members. No participating 
household members reported a history of CDI or chronic diarrhea. Among the 12 
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sampled household members, the only C. difficile-colonized subject was from a peri-
FMT household. None of the 8 pet fecal samples from peri-FMT households were C. 
difficile-positive. (No pet fecal samples were submitted from the only control household 
with pets.)  
 
Molecular characterization. Table 5 shows the by-household number of environmental 
samples obtained, number and distribution of C. difficile-positive sites, and 
corresponding pulsotype. Nine (90%) of 10 households that yielded ≥ 2 C. difficile 
isolates had a single C. difficile NAP type each, with the sole exception, peri-FMT 
household #5, having 2 different C. difficile NAP types (Figure 1). Anecdotally, peri-
FMT household #5, which had the highest proportion of C. difficile-positive surfaces 
(8/15, 53%), was the only household to report significant fecal contamination of the 
household environment during a R-CDI episode. Control household # 4, which had a C. 
difficile-positive vacuum cleaner, consisted of a single female whose now deceased 
husband had CDI 6 years prior to the study visit. Although impossible to confirm, we 
speculate that the C. difficile isolate found in the vacuum cleaner may have been present 
since the husband’s illness. 
Table 6 shows the molecular characteristics of the 35 C. difficile isolates. Two 
(6%) isolates were unavailable for molecular analysis, since archived stocks were 
nonviable. Of the 33 available isolates, all were toxin-producing, with the exception of 
the isolate from the diaper changing area of a young child in control household #2, which 
was a non-toxigenic strain (consistent with the high prevalence of asymptomatic C. 
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difficile colonization in young children). The most common molecular characteristics 
overall included NAP6 (11/33, 33%), toxinotype 0 (23/32, 72%), no binary toxin (25/33, 
76%), and no tcdC deletion (25/32, 78%). The epidemic BI/NAP1/027 C. difficile strain 
[1-2] was uncommon, occurring only in peri-FMT household # 4. NAP7 is the strain 
most commonly found in animals, however neither of the 2 households which contained 
NAP7 included pets. 
 
Discussion 
This pilot household survey involving R-CDI patients requiring FMT and community 
controls yielded findings that support three main conclusions. First, peri-FMT households 
had a significantly higher prevalence of C. difficile contamination (100%) than did post-
FMT and control households (38% each), and significantly more C. difficile-positive sites 
per household, which usually all yielded the same C. difficile genotype. Second, specific 
household sites (vacuum cleaner and bathroom areas) were relatively high-risk for C. 
difficile contamination. Third, C. difficile persisted in the household environment, as 
evidenced by findings in post-FMT households, although the positivity rate did appear to 
decrease as more time elapsed. These novel findings have potential clinical relevance, 
since whereas the hospital environment has received abundant attention in relation to CDI 
acquisition, household contamination has not yet been studied, and the increasing burden 
of R-CDI among non-hospitalized patients calls for closer attention to the household 
environment as a potential source for recurrence.  
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The significantly greater prevalence and extent of C. difficile contamination in 
peri-FMT households, as compared with post-FMT and control households, could mean 
that having a household member with CDI leads to household contamination, and/or that 
household contamination predisposes to R-CDI unless the CDI patient undergoes FMT to 
re-establish the normal gut microbiota. The possibility that the contaminated household 
environment may contribute to R-CDI has important practical implications that call for 
further study of this topic. Most C. difficile-positive households had between 1-3 positive 
environmental sites each. Peri-FMT household #5 was a notable exception, with over 
50% of environmental sites contaminated, which anecdotally might be explained by the 
significant fecal contamination of the household environment that reportedly occurred 
during the case patients’ most recent R-CDI episode. Overt fecal contamination of the 
household environment was not reported by any other household. Whether fecal 
incontinence is a risk factor for R-CDI due to more extensive environmental 
contamination warrants further study.  
Among the 10 households with ≥ 2 C. difficile-positive samples, all isolates from 
a given household represented the same PFGE NAP type, with the exception of peri-FMT 
household # 5, which had 2 separate NAP types. Some CDI patients develop R-CDI due 
to a different C. difficile strain than caused the initial episode, especially with long 
durations between R-CDI episodes [19-22]. Additionally, fecal samples from a single 
CDI episode may contain multiple C. difficile strains [23]. Either or both of these 
phenomena could explain the finding of multiple C. difficile types within a patient and 
their household. 
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The vacuum cleaner was the most common C. difficile-positive site. This likely 
reflects some combination of its function as an aggregator (by sampling extensive surface 
areas within the home), the difficulty with using potentially damaging sporicidal agents 
to clean carpeted floors/rugs, and the infeasibility of cleaning the vacuum cleaners 
interior. Whether C. difficile-contaminated vacuum cleaners constitute a reservoir, 
potentially leading to transmission/acquisition (via airborne dissemination or direct 
contact) and new CDI episodes, is unknown. 
Not surprisingly, bathroom sites were also frequently contaminated. Most 
households reported regular bathroom cleanings, including with bleach. Peri-FMT 
households had the highest reported cleaning frequency and rates of bleach use, likely 
reflecting prior knowledge regarding C. difficile transmission and anxiety induced by 
their extensive R-CDI history. Although this robust cleaning history seemingly conflicts 
with these households’ high C. difficile prevalence, the household cleaning survey 
addressed only cleaning frequency and bleach use, not specifics such as which particular 
areas within a given site were cleaned (e.g., whether toilet cleaning included the handle, 
seat, and/or bowl), whether the bleach product was fresh, how long bleach dwelled before 
being removed, etc. Therefore, sites conceivably were not cleaned thoroughly/properly, 
which could allow C. difficile to persist despite regular bleach cleaning.  
In this regard, hospital-based studies have shown that suboptimal cleaning 
techniques are insufficient to kill C. difficile spores, with 7/9 (78%) C. difficile-
contaminated hospital rooms remaining C. difficile-positive after routine terminal bleach 
cleaning by hospital housekeeping staff, as compared with only 1/9 (11%) after intensive 
 
 
13 
 
 
bleach cleaning by dedicated research staff [24]. A reason commonly cited for the low 
overall success of routine hospital room decontamination is the wide variability in 
cleaning techniques [25]. A study evaluating contamination of healthcare workers’ hands 
also suggested that daily focused cleaning actually may be required to decrease hospital 
room contamination [26]. Similar considerations may apply in the household, with 
insufficient cleaning thoroughness or frequency possibly allowing persistent surface 
contamination despite use of bleach products. A goal for future research would be 
identify effective and affordable approaches to household C. difficile contamination, and 
to study them in relation to acquisition of C. difficile and R-CDI risk. 
This study has several limitations. First, the cross-sectional, point-prevalence 
design may have missed transient C. difficile colonization of people, pets, and/or the 
environment that nonetheless might contribute to recurrence. For instance, C. difficile 
colonization in healthy dogs has been shown to be very transient [10]. Second, the small 
number of participating households limits statistical power. Third, since this was a pilot 
prevalence survey, no effort was made to quantify the amount of C. difficile present, 
which conceivably could vary in relation to study group or any of the other 
epidemiological variables, and might influence transmission risk. Fourth, previous and 
current C. difficile fecal isolates were lacking from most peri-FMT patients for 
comparison with their household environmental isolates, since specimens were 
unavailable from the patients’ prior CDI episodes and many subjects had extensive recent 
oral vancomycin use, so unsurprisingly were C. difficile-negative when sampled. Fifth, 
poor recall and/or incomplete honesty may have reduced survey validity. Sixth, most 
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households reported recent household cleaning, despite our request for no extra cleaning 
prior to the study visit. Although we nonetheless found frequent C. difficile 
contamination, even more samples conceivably might have been positive without the 
extra cleaning. Lastly, since the FMT households included only extreme cases of R-CDI, 
the results may not be broadly applicable, e.g., to patients after a first CDI episode. 
At present, whether C. difficile environmental contamination is a cause or simply 
a consequence of R-CDI is unknown. Future research should include longitudinal 
household surveillance for changes in the prevalence, density, and distribution of C. 
difficile contamination, in relation to R-CDI. If persistence of spores in the household 
environment leads to recolonization and/or reinfection of patients, and effective methods 
of household C. difficile decontamination can be identified, intensified household 
cleaning approaches, akin to those already used in hospitals, conceivably could lead to 
reduced R-CDI rates. 
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Table 1. Household demographics of subjects with recurrent Clostridium difficile infection (R-
CDI), peri-fecal microbiota transplantation (FMT) and post-FMT, and subjects in control 
households. 
Demographics Peri-FMT            
(n = 8) 
Post-FMT            
(n = 8) 
Control      
(n = 8) 
Age (years), mean ± SD 69 ± 14 70 ± 14 68 ± 7 
No. female (%) 5 (62) 6 (75) 8 (100) 
Time (days) since FMT, mean ± SD, 
(median) † 
-25 ± 78a, † (2) 443 ± 280b, † 
(399) 
N/A 
R-CDI duration (mo.)c, mean ± SD 10.1 ± 8.3 7.6 ± 3.7 N/A 
No. of CDI episodes, mean ± SD 3.6 ± 1.0 4.3 ± 1.3 N/A 
CDI requiring hospitalization, no. (%) 3 (38) 5 (67) N/A 
Healthcare facility exposure in past 6 
mo.d, no. (%)  
8 (100) 6 (75) 6 (75) 
Antibiotic use in past 12 mo.e, no. (%) 5 (63) 5 (63) 1 (13) 
Acid reducing medicationf use, no. (%) 1 (13) 5 (63) 1 (13) 
Diarrhea at time of study visit, no. (%) 3 (38) 2 (25) 1 (13) 
No. household members (mean, range) 10 (1.25, 0-5) 6 (0.75, 0-3) 7 (0.88, 0-3) 
Age (years) of household members, 
mean ± SD 
59 ± 15 58 ± 21 57 ± 24 
No. pets (mean per household) 8 (0.8) 6 (0.75) 2 (0.25) 
Household cleaning frequency,g mean 
± SD† 
4 ± 0.6† 3.2 ± 0.5† 3.4 ± 0.7 
No. bleach cleaning (%) 6 (75) 6 (75) 4 (50) 
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Hand washing,h mean ± SD 4.8 ± 0.7 5 ± 0 4.9 ± 0.4 
CDI knowledge,i mean ± SD 6.8 ± 1.3 6.6 ± 2.4 7.9 ± 1.9 
No. with index subject with ≥ 2 
underlying medical conditionsg (%)‡ 
5 (62) ‡ 4 (50) 0 (0) ‡ 
†P < 0.05 for comparison of peri-FMT to post-FMT households using student’s t-test (2-sided). 
‡P < 0.05 for comparison of peri-FMT to control households using Fisher’s exact test (2-sided). 
aMean time since FMT is 2.4 ± 5.6 excluding outlier of – 217 days (FMT delayed unexpectedly 
after study visit due to chemotherapy). 
bMean ± SD for 6 months post-FMT group is 197 ± 36, mean ± SD for 2 years post-FMT group is 
689 ± 143. 
cDuration is prior to FMT or study visit (in case of subject whose FMT was delayed unexpectedly 
for 217 days) for peri-FMT group, prior to FMT for post-FMT group. 
dExposure is defined as > 1 hour spent in a hospital, emergency room/urgent care, outpatient 
clinic, hemodialysis unit, or long term care facility. 
eAntibiotic use did not include antibiotics used for CDI therapy. 
fProton pump inhibitors and/or H2 receptor blockers. 
gHousehold cleaning frequency is mean of cleaning frequency for each environmental surface 
sampled in the household, with 5 = < 1/week, 4 = 1/week, 3 = every other week, 2 = 1/month, 1 = 
< 1/month, 0 = never. 
h5 = always, 4 = most of the time, 3 = some of the time, 2 = rarely, 1 = never. 
iNumber of questions correct out of 9 total questions regarding CDI risk factors. 
jChecklist of underlying conditions assessed included diabetes, lung disease, heart disease 
(including hypertension), liver disease, cancer, rheumatologic disease, inflammatory bowel 
disease, recipient of bone marrow or solid organ transplant. 
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Table 2. Isolation of Clostridium difficile from environmental and fecal samples obtained during 
household surveillance in relation to fecal microbiota transplantation (FMT). 
 Proportion positive for C. difficile (%) 
Household 
group (no. 
households) 
Householdsa Environmental 
samples 
Case 
patients 
Household 
members 
Pets 
Peri-FMT (8) 8/8 (100)b 21/106 (19)c 2/8 (25) 1/9 (11) 0/8 (0) 
Post-FMT (8)      
    6 mo. (4) 2/4 (50) 7/57 (12)d N/Ae N/Ae N/Ae 
    2 yrs. (4) 1/4 (25) 1/54 (2) N/Ae N/Ae N/Ae 
Control (8) 3/8 (38)b 3/109 (3)c,d 0/8 (0) 0/3 (0) 0/0 (0) 
aIndicates ≥ 1 sample (environmental or fecal) in the household positive for C. difficile. 
bP = 0.025, cP = 0.001, dP = 0.03 compared to control (Fisher’s exact test, two tailed). 
eN/A, not applicable; fecal samples were not collected from post-FMT households. 
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Table 3. Number of corea environmental samples positive for Clostridium difficile according to household group membership and fecal microbiota 
transplantation (FMT) status. 
Household 
group  
Number of core environmental samples C. difficile-positive, mean ± SE 
Unadjusted Adjustedb based on: 
Household 
members,      
mean no. 
Case 
patient, 
mean age 
Household 
members, 
mean age 
Pets,    
mean no. 
Household 
cleaning 
frequency 
Bleach 
cleaning 
Peri-FMT  2.63 ± 0.75 2.60 ± 0.55 2.62 ± 0.63 1.72 ± 0.21 2.75 ± 0.74 2.80 ± 0.99 2.67 ± 0.76 
Post-FMT  1.00 ± 0.53 0.86 ± 0.45 0.99 ± 0.55 0.62 ± 0.47 1.00 ± 0.55 0.95 ± 0.53 1.02 ± 0.53 
Control 0.25 ± 0.15 0.23 ± 0.14 0.31 ± 0.18 0.16 ± 0.14 0.22 ± 0.14 0.24 ± 0.15 0.24 ± 0.15 
a Sites sampled in most or all households. 
bAdjustment was done using Poisson regression with robust covariance estimators.
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Table 4. Origin of 31 Clostridium difficile-positive corea environmental samples from surveillance of 24 peri-fecal microbiota transplant (FMT), 
post-FMT, and control households. 
Environmental site No. 
samplesb 
C. difficile-positive, no. 
(% total samples) 
Usual cleaning frequency,          
OR (95% CI)c 
Bleach cleaning, OR 
(95% CI)c 
Vacuum cleaner 27b 11 (41) 1.8 (0.98 – 3.4) -- 
     Peri-FMT 9 6 (67) -- -- 
     Post-FMT 9 3 (33) -- -- 
     Control 9 2 (22) -- -- 
Toilet 30b 8 (27) 3.37 (0.9 – 13.1) 0.55 (0.08 – 3.9) 
     Peri-FMT 10 7 (70) -- -- 
     Post-FMT 11 1 (9) -- -- 
Bathroom sink/faucet 29b 5 (17) N/Ad 0.60 (0.05 – 6.8) 
     Peri-FMT 9 4 (44) -- -- 
     Post-FMT 10 1 (10) -- -- 
Computer 24b 2 (8) N/Ae N/Ae 
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     Peri-FMT 7 1 (14) -- -- 
     Post-FMT 9 1 (11) -- -- 
Bathroom door/light 
switch 
27b 1 (4) N/Ae N/Ae 
     Post-FMT 9 1 (11) -- -- 
Microwave 24b 1 (4) N/Ae N/Ae 
     Peri-FMT 8 1 (13) -- -- 
Refrigerator 24b 1 (4) N/Ae N/Ae 
     Peri-FMT 8 1 (13) -- -- 
Remote 24b 1 (4) N/Ae N/Ae 
     Peri-FMT 7 1 (14) -- -- 
Telephone 24b 1 (4) N/Ae N/Ae 
     Post-FMT 8 1 (13) -- -- 
aCore sites excluded pet food/water dishes and diaper changing areas, since these were not tested for most households (pet foot/water dishes = 8 
households, diaper changing area = 1 household). 
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bIncludes total number of samples obtained from that site for all 24 households surveyed. Number may be > 24 due to duplicate sites sampled in a 
household (e.g., 2 separate toilets in 1 household). Results per individual household group may not sum to total as negative household groups not 
shown. 
cSite-specific logistic regression, analyzed by using samples collected at each site for all household groups total, not per individual household 
group. 
dUnable to determine, as all households with a Clostridium difficile-positive bathroom sink reported the same cleaning frequency. 
eUnable to determine due to low number of Clostridium difficile-positive sites. 
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Table 5. Individual household surveillance results of Clostridium difficile-positive environmental (environ.) sites, including pulsed-field gel 
electrophoresis (PFGE) type. 
Household 
group 
Household 
number 
No. of environ. 
samples  
C. difficile-positive 
environ. samples (row %) 
C. difficile-positive sites PFGE type 
Peri-FMT  1a 15 1 (7) Vacuum NAP10 
 2 14 2 (14) Toilet, vacuum NAP2 
 3 13 3 (23) Toilet, bathroom sink, vacuum NAP7 
 4 12 2 (17) Remote, vacuum NAP1 
 5 15 8 (53) Microwave, toilet #2 NAP7 
    Refrigerator, computer, toilet # 1, 
bathroom sink #1 and #2, vacuum 
NAP6 
 6b 14 2 (14) Toilet, bathroom sink NAP6 
 7b 13 1 (8) Toilet NAP4 
 8 16 2 (13) Toilet, vacuum NAP6 
Post-FMT  1 16 0 (0) --  
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 2 13 4 (31) Bathroom sink, bathroom door, 
telephone, vacuum 
NAP11 
 3 14 0 (0) --  
 4 16 3 (19) Computer, vacuum #1 NAP11 
    Vacuum #2 NDc 
 5 13 0 (0) --  
 6 14 1 (7) Toilet Unnamedd  
 7 15 0 (0) --  
 8 13 0 (0) --  
Control 1 15 0 (0) --  
 2 14 1 (7) Diaper changing areae Unnamedd 
 3 13 0 (0) --  
 4 13 1 (8) Vacuum NDc 
 5 13 0 (0) --  
 6 13 0 (0) --  
 7 14 1 (7) Vacuum NAP4 
 
 
24 
 
 
 8 16 0 (0) --  
aHousehold member C. difficile positive.     
bCase patient C. difficile positive. 
CND, not done: archived stocks did not regrow for PFGE analysis despite extensive efforts. 
dUnnamed (CD isolate profile was not ≥ 80% similar to a Center for Disease Control and Preventions NAP standard). 
eNon-toxigenic strain (PCR negative for tcdC gene and toxinotyping (toxins A and B), and positive for pathogenicity locus gene).
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Table 6. Molecular characteristics of 35 Clostridium difficile isolates (32 environmental, 3 
human). 
Household Source Binary toxin 
(cdtB) 
Toxino
-type 
tcdC 
deletion 
PFGEa type 
Peri-FMT 1 Vacuum Neg. 0 0 bpb  NAP10 
Peri-FMT 1 Household member Neg. 0 0 bp  NAP10 
Peri-FMT 2 Toilet Neg. 0 0 bp  NAP2 
Peri-FMT 2 Vacuum Neg. 0 0 bp  NAP2 
Peri-FMT 3 Toilet Pos. V 39 bp  NAP7 
Peri-FMT 3 Bathroom sink Pos. V 39 bp  NAP7 
Peri-FMT 3 Vacuum Pos. V 39 bp  NAP7 
Peri-FMT 4 Remote Pos. III 18 bp  NAP1 
Peri-FMT 4 Vacuum Pos. III 18 bp  NAP1 
Peri-FMT 5 Microwave Pos. V 39 bp  NAP7 
Peri-FMT 5 Refrigerator Neg. 0 0 bp  NAP6 
Peri-FMT 5 Toilet #1 Neg. 0 0 bp  NAP6 
Peri-FMT 5 Bathroom sink #1 Neg. 0 0 bp  NAP6 
Peri-FMT 5 Computer Neg. 0 0 bp  NAP6 
Peri-FMT 5 Toilet #2 Pos. V 39 bp  NAP7 
Peri-FMT 5 Bathroom sink #2 Neg. 0 0 bp  NAP6 
Peri-FMT 5 Vacuum Neg. 0 0 bp  NAP6 
Peri-FMT 6 Toilet Neg. 0 0 bp  NAP6 
Peri-FMT 6 Bathroom sink Neg. 0 0 bp  NAP6 
Peri-FMT 6 Case patient Neg. 0 0 bp  NAP6 
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Peri-FMT 7 Toilet Neg. N/Ac 0 bp NAP4 
Peri-FMT 7 Case patient Neg. N/Ac 0 bp NAP4 
Peri-FMT 8 Toilet  Neg. 0 0 bp  NAP6 
Peri-FMT 8 Vacuum Neg. 0 0 bp  NAP6 
Post-FMT 2 Bathroom sink Neg. 0 0 bp  NAP11 
Post-FMT 2 Bathroom door Neg. 0 0 bp  NAP11 
Post-FMT 2 Telephone Neg. 0 0 bp  NAP11 
Post-FMT 2 Vacuum Neg. 0 0 bp  NAP11 
Post-FMT 4 Computer Neg. 0 0 bp  NAP11 
Post-FMT 4 Vacuum 1 Neg. 0 0 bp  NAP11 
Post-FMT 4 Vacuum #2 N/Ad N/Ad N/Ad N/Ad 
Post-FMT 6 Toilet Neg. 0 0 bp  Unnamede 
Control 3 Diaper changing 
area 
Neg. N/Af N/Af Unnamede 
Control 6 Vacuum N/Ad N/Ad N/Ad N/Ad 
Control 9 Vacuum Neg. 0 0 bp  NAP4 
aPulsed-field gel electrophoresis. 
bbp = base pair. 
cUnable to distinguish between toxinotypes XVIII and XXIX due to identical appearance of A3 
fragment between the two toxinotypes. 
dUnable to complete molecular characterization since archived stocks did not regrow. 
eUnnamed (household C. difficile isolate profile was not ≥ 80% similar to a defined Center for 
Disease Control and Preventions NAP standard). 
fNon-toxigenic strain, so toxins A, B and tcdC genes not present. 
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Figure 1. Pulsed-field gel electrophoresis results of a representative selection of Clostridium 
difficile isolates obtained from household surveillance. (A) Peri-fecal microbiota transplantation 
(FMT) household #4, with indistinguishable NAP1 isolates in lanes 1 (remote control) and 2 
(vacuum).  (B) Peri-FMT household #5, with indistinguishable NAP7 isolates in lanes 1 
(microwave door) and 2 (toilet #2), and indistinguishable NAP6 isolates in lanes 3 (refrigerator), 
4 (toilet #1), 5 (bathroom sink #1), 6 (computer), 7 (bathroom sink #2), and 8 (vacuum). (C) Peri-
FMT household #6, with indistinguishable NAP6 isolates in lanes 1 (toilet), 2 (bathroom sink), 
and 3 (case patient fecal sample). (D) Post-FMT household #2, with indistinguishable NAP11 
isolates in lanes 1 (bathroom sink), 2 (bathroom door), 3 (telephone), and 4 (vacuum). 
 
 
  
 
 
28 
 
 
References 
1. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain 
of Clostridium difficile. N Engl J Med, 2005; 353(23):2433-2441. 
2. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak 
of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J 
Med, 2005; 353: 2442-2449. 
3. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 
163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol, 2002; 97: 1769-
1775.  
4. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the 
environment and contacts of patients with antibiotic-associated colitis. J Infect Dis, 1981; 
143: 42-50. 
5. Cohen SH, Gerding DN, Olsen MM, et al. Clinical practice guidelines for Clostridium 
difficile infection in adults: 2010 update by the society for healthcare epidemiology of 
America (SHEA) and the infectious diseases society of America (IDSA). Infect Control 
Hosp Epidemiol, 2010; 31(5): 431-455. 
6. Mayfield JL, Leet T, Miller J, et al. Environmental control to reduce transmission of 
Clostridium difficile. Clin Infect Dis, 2000; 31: 995-1000.  
7. Bartlett JD, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile 
infection. Clin Infect Dis, 2008; 46(1): S43-S49. 
8. Riggs MM, Sethi AK, Zabarsky TF, et al. Asymptomatic carriers are a potential source 
for transmission of epidemic and nonepidemic Clostridium difficile strains among long-
term care facility residents. Clin Infect Dis, 2007; 45 (8): 992-998. 
 
 
29 
 
 
9. Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: 
implications for disease in later life. J Pediatr Gastroenterol Nutr, 2010; 51(1): 2-7. 
10. Weese JS, Finely R, Reid-Smith RR, et al. Evaluation of Clostridium difficile in dogs and 
the household environment. Epidemiol Infect, 2010; 138(8): 1100-1104. 
11. Riley TV, Adams JE, O’Neill GL, et al. Gastrointestinal carriage of Clostridium difficile 
in cats and dogs attending veterinary clinics.  Epidemiol Infect, 1991; 107: 659-665. 
12. Arroyo LG, Rousseau BM, Willey CE, et al. Use of a selective enrichment broth to 
recover Clostridium difficile from stool swabs stored under different conditions. J Clin 
Microbiol, 2005; 43: 5341-5343. 
13. Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C. Definition of 
the single integration site of the pathogenicity locus in Clostridium difficile. Gene, 1996. 
181: 29-38. 
14. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M. Production of actin-
specific ADP-riposyltransferase (binary toxin) by strains of Clostridium difficile. FEMS 
Microbiol Lett, 2000; 186: 307-312. 
15. Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and 
polymorphism in the putative negative regulator of toxin production (TcdC) among 
Clostridium difficile clinical isolates. J Clin Microbiol, 2002; 40: 3470-3475. 
16. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmee M. A novel toxinotyping 
scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J 
Clin Microbiology, 1998; 36: 2240-2247. 
17. Rupnik, M. Clostridium difficile toxinotypes. Available at http://www.mf.uni-
mb.si/mikro/tox/. Accessed 22 October 2013. 
18. Killgore G, Thompson A, Johnson S, et al. Comparison of seven techniques for typing 
international epidemic strains of Clostridium difficile: restriction endonuclease analysis, 
 
 
30 
 
 
pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus 
variable-number tandem-repeat analysis, amplified fragment length polymorphism, and 
surface layer protein A gene sequence typing. J Clin Microbiol, 2008; 46 (2): 431-437. 
19. Eckstein BC, Adams DA, Eckstein EC, et al. Reduction of Clostridium difficile and 
vancomycin-resistant Enterococcus contamination of environmental surfaces after an 
intervention to improve cleaning methods. BMC Infect Dis, 2007; 7: 61. 
20. Boyce JM, Havill NL, Lipka A, Havill H, Rizvani R. Variations in hospital daily cleaning 
practices. Infect Control Hosp Epidemiol, 2010; 31: 99-101. 
21. Kundrapu S, Sunkesula V, Jury LA, Sitzlar BM, Donskey CJ. Daily disinfection of high-
touch surfaces in isolation rooms to reduce contamination of healthcare workers’ hands. 
Infect Control Hosp Epidemiol, 2012; 33: 1039-1042. 
22. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit J. Epidemiology of 
recurrences or reinfections of Clostridium difficile -associated diarrhea. J Clin Microbiol, 
2000; 38: 2386-2388. 
23. Kamboj M, Khosa P, Kaltsas A, Babady NE, Son C, Sepkowitz KA. Relapse versus 
reinfection: surveillance of Clostridium difficile infection. Clin Infect Dis, 2011; 53: 
1003-1006. 
24. Figueroa I, Johnson S, Sambol SP, Goldstein EJC, Citron DM, Gerding DN. Relapse 
versus reinfection: recurrent Clostridium difficile infection following treatment with 
fidaxomicin or vancomycin. Clin Infect Dis, 2012; 55: S104-S109. 
25. Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH. Association of 
relapse of Clostridium difficile with BI/NAP1/027. J Clin Microbiol, 2012; 50: 4078-
4082. 
26. Eyre DW, Walker S, Griffiths D, et al. Clostridium difficile mixed infection and 
reinfection. J Clin Microbiol, 2012; 50: 142-144. 
